Company / Financials
Q32 Bio Inc. Financials
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$0
FY2025 · +100.0% YoY
Net Income
-$47.7M
FY2025 · +11.2% YoY
Profit Margin
-
FY2025 · net income / revenue
ROE
-841.1%
FY2025 · return on equity
Total Assets
$61.8M
FY2025
Total Debt
-
FY2025
Equity
$5.7M
FY2025
ROA
-77.3%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$0+100.0% YoYNet Income HistoryProfit after all expenses and taxes-$47.7M+11.2% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$66.1M-37.0% YoYSG&A Expense HistorySelling, general, and administrative expenses$18.0M+81.9% YoYR&D Expense HistoryResearch and development spending$48.1M+51.7% YoYInterest Expense HistoryCost of borrowing and debt obligations$2.8M+88.8% YoYIncome Tax HistoryTotal income tax expense$21.0K-93.4% YoYEPS (Basic) HistoryBasic earnings per share-$5.12+96.7% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$6.58+95.7% YoYShares Outstanding HistoryWeighted average diluted shares outstanding12.2M+3292.3% YoY